ASHLEY HUGHES: Open Payments
NPI 1912486689 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 51 payments from 12 companies in 2025. Trend: 2023 $551 · 2024 $911 · 2025 $971
Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $202 |
| ABBVIE INC. | 11 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $118 |
| Axsome Therapeutics, Inc. | 5 | $117 |
| Exact Sciences Corporation | 5 | $108 |
| Lilly USA, LLC | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Astellas Pharma US Inc | 1 | $30 |
| Lundbeck LLC | 1 | $23 |
Products named: CAPLYTA, Auvelity, VRAYLAR, FARXIGA, JARDIANCE, AIRSUPRA, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across IN — which companies pay providers there.
